Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Oakes

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Journal of Parkinson'S Disease|September 6, 2024
Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII TrialsChadwick W Christine, Peggy Auinger, Esther A R Forti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Interrater agreement in the assessment of motor manifestations of Huntington's diseasePenelope Hogarth, Elise Kayson, Karl Kieburtz, et al.
Air Quality, Atmosphere, & Health|November 5, 2014
Acute Changes in Ambient Temperature Are Associated With Adverse Changes in Cardiac RhythmErin B Wasserman, Wojciech Zareba, Mark J Utell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2022
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory ModelingSheng Luo, Haotian Zou, Glenn T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findingsLama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2017
Cognition and the course of prodromal Parkinson's diseaseDaniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
Plos Currents|December 6, 2011
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD StudyRay Dorsey, Kevin Biglan, Shirley Eberly, et al.
Particle and Fibre Toxicology|July 17, 2014
Inhalation of ultrafine carbon particles alters heart rate and heart rate variability in people with type 2 diabetesRathin Vora, Wojciech Zareba, Mark J Utell, et al.
Movement Disorders Clinical Practice|October 27, 2018
Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's DiseaseRoger Kurlan, Bernard Ravina, Shirley Eberly, et al.
Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Journal of Parkinson'S Disease|September 6, 2024
Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII TrialsChadwick W Christine, Peggy Auinger, Esther A R Forti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Interrater agreement in the assessment of motor manifestations of Huntington's diseasePenelope Hogarth, Elise Kayson, Karl Kieburtz, et al.
Air Quality, Atmosphere, & Health|November 5, 2014
Acute Changes in Ambient Temperature Are Associated With Adverse Changes in Cardiac RhythmErin B Wasserman, Wojciech Zareba, Mark J Utell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2022
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory ModelingSheng Luo, Haotian Zou, Glenn T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findingsLama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2017
Cognition and the course of prodromal Parkinson's diseaseDaniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
Plos Currents|December 6, 2011
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD StudyRay Dorsey, Kevin Biglan, Shirley Eberly, et al.
Particle and Fibre Toxicology|July 17, 2014
Inhalation of ultrafine carbon particles alters heart rate and heart rate variability in people with type 2 diabetesRathin Vora, Wojciech Zareba, Mark J Utell, et al.
Movement Disorders Clinical Practice|October 27, 2018
Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's DiseaseRoger Kurlan, Bernard Ravina, Shirley Eberly, et al.
Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.
Pageof 12